Pharmaron Beijing Co., Ltd. (SHE:300759)
China flag China · Delayed Price · Currency is CNY
40.90
-0.70 (-1.68%)
Nov 17, 2026, 3:04 PM CST

Pharmaron Beijing Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Pharmaron Beijing stock has a consensus rating of "Buy" and an average price target of ¥50.40. The average 1-year stock price forecast is 23.23% higher than the current stock price, while the lowest is ¥33.80 (-17.36%) and the highest is ¥60.50 (+47.92%).

Price Target: ¥50.40 (+23.23%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥33.80¥50.40¥50.60¥60.50
Change-17.36%+23.23%+23.72%+47.92%

Analyst Ratings

The average analyst rating for Pharmaron Beijing stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy766677
Buy233322
Hold222223
Sell111111
Strong Sell000000
Total121212121213

Financial Forecast

Revenue This Year
16.71B
from 14.10B
Increased by 18.53%
Revenue Next Year
20.15B
from 16.71B
Increased by 20.59%
EPS This Year
1.18
from 0.87
Increased by 36.18%
EPS Next Year
1.48
from 1.18
Increased by 25.37%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Jan 1, 2023Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
7.44B10.27B11.54B12.28B14.10B16.71B
Revenue Growth
45.00%37.92%12.39%6.39%14.82%18.53%
Gross Profit
2.68B3.76B4.12B4.18B4.89B5.53B
Gross Margin
35.95%36.67%35.67%34.09%34.70%33.09%
Operating Income
1.45B1.67B1.69B1.72B2.05B2.52B
Net Income
1.66B1.37B1.60B1.79B1.66B1.97B
EPS
----0.871.18
EPS Growth
----38.72%36.18%
Forward PE
59.2335.7525.7226.2224.7234.59
Dividend / Share
0.200.200.200.200.200.24
Dividend Growth
50.04%----20.90%
Free Cash Flow
----551.97M-211.00M
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High16.8B
Avg16.7B
Low16.5B

Revenue Growth

Revenue Growth202620272028
High
19.5%
Avg
18.5%
Low
17.3%

EPS Forecast

EPS202620272028
High1.23
Avg1.18
Low1.12

EPS Growth

EPS Growth202620272028
High
41.9%
Avg
36.2%
Low
29.0%